Información de Bausch + Lomb Corp, dividendo de Bausch + Lomb Corp, actividades de los accionistas y más

Más Datos de Bausch + Lomb Corp Compañía

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Información de Bausch + Lomb Corp



Símbolo de cotizaciónBLCO

Nombre de la empresaBausch + Lomb Corp

Fecha de salida a bolsaMay 06, 2022

Director ejecutivoMr. Brenton L. (Brent) Saunders, J.D.

Número de empleados13500

Tipo de seguridadOrdinary Share

Fin del año fiscalMay 06

Dirección520 Applewood Crescent

CiudadVAUGHAN

Bolsa de valoresNYSE Consolidated

PaísCanada

Código postalL4K 4B4

Teléfono19082552864

Sitio Webhttps://ir.bausch.com/

Símbolo de cotizaciónBLCO

Fecha de salida a bolsaMay 06, 2022

Director ejecutivoMr. Brenton L. (Brent) Saunders, J.D.

Ejecutivos de Bausch + Lomb Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Luc Bonnefoy

President - Surgical

77.36K

+8.63%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

68.18K

+35.10%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

--

Ms. Sarah B. Kavanagh

Independent Director

--

Mrs. Nathalie Bernier

Independent Director

--

Mr. Andrew J. Stewart

President - Global Pharmaceuticals and International Consumer

--

Mr. Sam A. Eldessouky

Chief Financial Officer, Executive Vice President

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Brenton L. (Brent) Saunders, J.D.

Chairman of the Board, Chief Executive Officer

352.13K

+162.32%

Mr. Luc Bonnefoy

President - Surgical

77.36K

+8.63%

Dr. Yehia Hashad, M.D.

Executive Vice President - Research & Development, Chief Medical Officer

68.18K

+35.10%

Mr. Russel C. Robertson

Independent Director

64.91K

+53.22%

Dr. Andrew Charles Von Eschenbach, M.D.

Independent Director

62.09K

+55.01%

Mr. A. Robert D. Bailey, J.D.

Executive Vice President, Chief Legal Officer

--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

OTC

482.00M

37.72%

Devices

472.00M

36.93%

Pharmaceuticals

260.00M

20.34%

Branded and other Generics

58.00M

4.54%

Other revenues

6.00M

0.47%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

OTC

482.00M

37.72%

Devices

472.00M

36.93%

Pharmaceuticals

260.00M

20.34%

Branded and other Generics

58.00M

4.54%

Other revenues

6.00M

0.47%

Estadísticas de accionistas

Actualizado: lun., 18 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

Bausch Health Companies Inc

87.68%

Icahn Associates Corporation

0.99%

Deutsche Bank Securities Inc.

0.96%

Alberta Investment Management Corporation

0.92%

D. E. Shaw & Co., L.P.

0.74%

Otro

8.71%

Accionistas

Proporción

Bausch Health Companies Inc

87.68%

Icahn Associates Corporation

0.99%

Deutsche Bank Securities Inc.

0.96%

Alberta Investment Management Corporation

0.92%

D. E. Shaw & Co., L.P.

0.74%

Otro

8.71%

Tipos de accionistas

Accionistas

Proporción

Corporation

87.68%

Hedge Fund

3.49%

Investment Advisor/Hedge Fund

3.31%

Research Firm

1.54%

Investment Advisor

1.52%

Sovereign Wealth Fund

0.92%

Individual Investor

0.48%

Pension Fund

0.25%

Family Office

0.24%

Otro

0.57%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

246

39.05M

11.03%

-24.81M

2025Q2

263

350.71M

99.08%

-19.09M

2025Q1

273

350.60M

99.12%

-19.40M

2024Q4

262

347.48M

98.58%

-23.77M

2024Q3

257

349.38M

99.14%

-19.72M

2024Q2

260

352.10M

99.92%

-21.43M

2024Q1

247

349.79M

99.91%

-25.18M

2023Q4

237

351.31M

100.35%

-21.66M

2023Q3

219

355.43M

101.52%

-16.80M

2023Q2

207

357.28M

102.06%

-12.23M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Bausch Health Companies Inc

310.45M

87.68%

--

Mar 24, 2025

Icahn Associates Corporation

3.50M

0.99%

--

Jun 30, 2025

Deutsche Bank Securities Inc.

3.41M

0.96%

-89.90K

-2.57%

Jun 30, 2025

Alberta Investment Management Corporation

3.27M

0.92%

+258.00K

+8.58%

Mar 31, 2025

D. E. Shaw & Co., L.P.

2.61M

0.74%

+728.68K

+38.79%

Jun 30, 2025

GoldenTree Asset Management, LP

2.58M

0.73%

+334.92K

+14.90%

Jun 30, 2025

Oaktree Capital Management, L.P.

2.52M

0.71%

+2.52M

--

Jun 30, 2025

Glenview Capital Management, LLC

1.55M

0.44%

+1.05M

+210.77%

Jun 30, 2025

Whitebox Advisors, L.L.C.

1.29M

0.36%

-331.23K

-20.41%

Jun 30, 2025

Nomura Securities Co., Ltd.

1.26M

0.35%

--

Jun 30, 2025

ETFs relacionados



Actualizado: dom., 2 de nov

Nombre

Proporción

Ballast Small/Mid Cap ETF

1.45%

Invesco RAFI Developed Mkts ex-US SM ETF

0.03%

BNY Mellon US Small Cap Core Equity ETF

0.03%

Schwab Fundamental International Small Equity ETF

0%

Goldman Sachs MarketBeta US 1000 Equity ETF

0%

Invesco Zacks Mid-Cap ETF

0%

QRAFT AI-Enhanced US Large Cap ETF

0%

AltShares Event-Driven ETF

0%

DFA Dimensional International Core Equity 2 ETF

0%

BNY Mellon US Mid Cap Core Equity ETF

0%

Ballast Small/Mid Cap ETF

Proporción1.45%

Invesco RAFI Developed Mkts ex-US SM ETF

Proporción0.03%

BNY Mellon US Small Cap Core Equity ETF

Proporción0.03%

Schwab Fundamental International Small Equity ETF

Proporción0%

Goldman Sachs MarketBeta US 1000 Equity ETF

Proporción0%

Invesco Zacks Mid-Cap ETF

Proporción0%

QRAFT AI-Enhanced US Large Cap ETF

Proporción0%

AltShares Event-Driven ETF

Proporción0%

DFA Dimensional International Core Equity 2 ETF

Proporción0%

BNY Mellon US Mid Cap Core Equity ETF

Proporción0%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos